Evidence map›Paper›PMID 37925423›Full record

ArticleBMC health services research2023

Development of an intervention to manage benzodiazepine dependence and high-risk use in the context of escalating drug related deaths in Scotland: an application of the MRC framework.

Karen Berry, Catriona Matheson, Joe Schofield, Joshua Dumbrell, Tessa Parkes, Duncan Hill, Mary Kilonzo, Graeme MacLennan, Duncan Stewart, Trina Ritchie and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC health services research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 8 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 1 country.

Karen BerryUniversity of Stirling, Stirling, Scotland. karen.berry@stir.ac.uk.
Catriona MathesonUniversity of Stirling, Stirling, Scotland.
Joe SchofieldThe University of Edinburgh, Edinburgh, Scotland.
Joshua DumbrellUniversity of Stirling, Stirling, Scotland.
Tessa ParkesUniversity of Stirling, Stirling, Scotland.
Duncan HillNHS Lanarkshire, Lanarkshire, Scotland.
Mary KilonzoUniversity of Aberdeen, Aberdeen, Scotland.
Graeme MacLennanUniversity of Aberdeen, Aberdeen, Scotland.
Duncan StewartNHS Lothian, Edinburgh, Scotland.
Trina RitchieNHS Greater Glasgow and Clyde, Glasgow, Scotland.
Michael TurnerNHS Grampian, Aberdeen, Scotland.
University of Stirling · GBUniversity of Aberdeen · GBNHS Grampian · GBNHS Greater Glasgow and Clyde · GBNHS Lanarkshire · GBNHS Lothian · GBUniversity of Edinburgh · GB

Funding

Chief Scientist Office, Scottish Government Health and Social Care Directorate HIPS/20/09
6 · The paper itself

Abstract

backgroundScotland has the highest rate of drug related deaths (DRD) in Europe. These are deaths in people who use drugs such as heroin, cocaine, benzodiazepines and gabapentinoids. It is a feature of deaths in Scotland that people use combinations of drugs which increases the chance of a DRD. Many deaths involve 'street' benzodiazepines, especially a drug called etizolam. Many of the 'street' benzodiazepines are not licensed in the UK so come from illegal sources. People who use opiates can be prescribed a safer replacement medication (e.g., methadone). While guidance on management of benzodiazepines use highlights that there is little evidence to support replacement prescribing, practice and evidence are emerging.

aimTo develop an intervention to address 'street' benzodiazepines use in people who also use opiates.

methodsThe MRC Framework for Complex Interventions was used to inform research design. Co-production of the intervention was achieved through three online workshops with clinicians, academics working in the area of substance use, and people with lived experience (PWLE). Each workshop was followed by a PWLE group meeting. Outputs from workshops were discussed and refined by the PWLE group and then further explored at the next workshop.

resultsAfter these six sessions, a finalised logic model for the intervention was successfully achieved that was acceptable to clinicians and PWLE. Key components of the intervention were: prescribing of diazepam; anxiety management, sleep, and pain; and harm reduction resources (locked box and a range of tips), personal safety conversations, as well as a virtual learning environment.

conclusionA co-produced intervention was developed for next stage clinical feasibility testing.

Indexed as

Opiate AlkaloidsSubstance-Related DisordersBenzodiazepinesHumansHypnotics and SedativesScotlandBenzodiazepinesHypnotics and SedativesOpiate AlkaloidsBenzodiazepinesCo-productionDrug related deathsIntervention developmentOpiatesPolydrug usePWLE

Identifiers

PMID37925423
PMCPMC10625279
OpenAlexW4388348035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.